SpanishDrug Discovery Network https://validator.w3.org/feed/docs/rss2.html Juan José Lasarte Ponentes 2026 Poster’s virtual room 2026 Programme2026 Annalaura Mastrangelo Aritz Lasarte Cia Francisco Javier Ciriza Roustan Sarah chaudhry Karin Gyger Monika Grossen Israel Ramos Adrián Fernández Exhibitors and Sponsors XVIII SDDN Meeting 2026 XVIII SDDN Meeting 2026 Uncovering Novel Therapeutic Candidates for Alzheimer’s Disease Through Integrative Omics-Based Drug Repurposing Mariusz Milewski Sonsoles Rodríguez-Arístegui Quantitative Live-Cell Analysis Of GPCR Signaling Dynamics Using Endogenous Bioluminescent Reporters: From Ligand Engagement To Downstream Effector Activation 2001: A CRO (Contract Research Organization) Odyssey Partnering Sponsorship 2026 Posters – Information 2026 XVIII SDDN Meeting 2026 Leticia Ferreiro Home Exhibitors and Sponsors 2026 Description Transforming Drug Discovery: Generative Models and Electrostatic Complementarity Alba Mosteiro Couso Álvaro Ferrer Franco Ivan Cornella Taracido Jose Manuel Lopez Vilariño CARME PAMPIN JULIE MASSE Screening for novel inhibitors of Mycobacterium tuberculosis dihydrofolate reductase using structure-based virtual screening How and when to protect Drug Discoveries (DDs) through patents. Dialogue with Q&A between a researcher in DD and a patent attorney Ivan Marcos-Campos Rucaparib as a repurposed therapeutic strategy for Parkinson’s Disease: in vitro and in vivo validation. Paula Dominguez Lacueva página de prueba Jokin Juan Francisco Simon Silva Lara Garcia Varela Stefano Benvegnu TRANSLATING OMICS-DRIVEN DRUG REPURPOSING INTO EXPERIMENTAL MODELS OF ALZHEIMER’S DISEASE Juan Bautista Crespo García Sandra Elena Caballero Sánchez Andrea Zapater Amarlig Ferrigni